Bicycle Therapeutics plc
BCYC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $815 | $644 | $878 | $1,526 |
| - Cash | $880 | $526 | $339 | $439 |
| + Debt | $9 | $45 | $44 | $44 |
| Enterprise Value | -$55 | $162 | $583 | $1,131 |
| Revenue | $35 | $27 | $14 | $12 |
| % Growth | 30.8% | 86.5% | 23.6% | – |
| Gross Profit | -$138 | -$130 | $14 | $12 |
| % Margin | -390.3% | -480.1% | 100% | 100% |
| EBITDA | -$165 | -$183 | -$107 | -$64 |
| % Margin | -467.4% | -679.9% | -741.3% | -547.9% |
| Net Income | -$169 | -$181 | -$113 | -$67 |
| % Margin | -479.2% | -669.7% | -779.3% | -571.2% |
| EPS Diluted | -2.9 | -5.08 | -3.8 | -2.67 |
| % Growth | 42.9% | -33.7% | -42.3% | – |
| Operating Cash Flow | -$165 | -$61 | -$86 | -$15 |
| Capital Expenditures | -$1 | -$3 | -$19 | -$2 |
| Free Cash Flow | -$166 | -$64 | -$105 | -$17 |